OSUR - OraSure Technologies Inc Company Long-Term Debts

Graphic logo of OraSure Corp (OSUR)

OraSure Technologies (OSUR) generates revenue through the global supply of diagnostic systems for infection detection and genetic collection tools. Business stability relies on the retention of R&D personnel and experts in test production automation. Long-term debt stands at 0.01. The price chart below illustrates the performance of the issuer, which leads the rapid test segment for pharmacies and clinics thanks to unique patents for biomaterial collection.

OraSure Technologies (OSUR) - Company Long-Term Debts from 07/04/2022 to 10/29/2026

OraSure Technologies Inc - analytical breakdowns and key metrics (OSUR)

- share price and expert price forecast:
Share Price orasure.com|OSUR - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization OraSure|OSUR - Total Company Value
- book value of equity indicators:
Equity per Share OraSure|OSUR - Book Capitalization|Market Capitalization to Book Value Ratio orasure.com|OSUR - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity OraSure Technologies|OSUR - Long-Term Debt to Equity Ratio|Current Liabilities to Capital OraSure Corp|OSUR - Company Debts|Debts to Net Assets OraSure|OSUR - Company Long-Term Debts|Short-Term Debt Volume OraSure
Analysis of all company metrics:OSUR orasure.com
Manufactured products of OraSure

An analysis of long-term liabilities allows for an assessment of OraSure Technologies (OSUR) resilience to systemic shocks and government contract volatility. Dependence on public procurement and the shift toward at-home testing require a significant buffer to sustain R&D. This metric measures the volume of borrowed capital with a maturity exceeding one year, determining the business's financial leverage. By examining the company's long-term debt history, an investor can determine the balance between over-leverage risks and investment efficiency.

Who OraSure Technologies competes with

A: Company Long-Term Indebtedness|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN - Company Long-Term Debts|Cologuard (EXAS) - Company Long-Term Debt|Company Long-Term Indebtedness RVTY|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts anbio.com|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt QDEL (Quidel Corporation)|OPKO Corp - Company Long-Term Liabilities|CareDx (CDNA) - Long-Term Debt|MRVI - Company Long-Term Debt|Long-Term Debt Volume fulgentgenetics.com FLGT|LAB: Company Long-Term Debts|CTKB - Long-Term Debt Volume|Company Long-Term Debt Exagen Inc|MDxHealth, Inc. (MDXH) - Long-Term Debt Volume|Company Long-Term Debt Lucid Diagnostics Inc. (LUCD)|PRE - Long-Term Debt|Company Long-Term Debt Insight Molecular Diagnostics Inc IMDX|Company Long-Term Loans and Borrowings TRIB|ProPhase - Company Long-Term Debts|AIMD - Company Long-Term Debts|Co-Diagnostics, Inc. (CODX) - Company Long-Term Debt|HSCS - Long-Term Debt Volume|Company Long-Term Liabilities BMRA|Company Long-Term Debts Cardio Diagnostics Holdings, Inc.|Company Long-Term Debt Virax Biolabs Group Ltd (VRAX)|BJDX (Bluejay Diagnostics Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AWH (Aspira Women's Health)|acceleratediagnostics.com (AXDX) - Long-Term Debt|CNTG: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ENZ (Enzo Biochem, Inc.)|FRES (fresh2.co) - Company Long-Term Liabilities|GENE: Amount of Long-Term Liabilities|ME (23andMe Holding Co.) - Company Long-Term Debts|Long-Term Debt psychemedics.com PMD